Cargando…
Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
BACKGROUND: In congenital adrenal hyperplasia (CAH), long-term glucocorticoid treatment coupled with increased androgens may lead to undesirable metabolic effects. The aim of our report was to determine the prevalence of metabolic abnormalities and cardiovascular risk factors in a population of adul...
Autores principales: | Mnif, Mouna Feki, Kamoun, Mahdi, Mnif, Fatma, Charfi, Nadia, Naceur, Basma Ben, Kallel, Nozha, Rekik, Nabila, Mnif, Zainab, Sfar, Mohamed Habib, Sfar, Mohamed Tahar, Hachicha, Mongia, Abid, Mohamed |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510964/ https://www.ncbi.nlm.nih.gov/pubmed/23226639 http://dx.doi.org/10.4103/2230-8210.102995 |
Ejemplares similares
-
Brain magnetic resonance imaging findings in adult patients with congenital adrenal hyperplasia: Increased frequency of white matter impairment and temporal lobe structures dysgenesis
por: Mnif, Mouna Feki, et al.
Publicado: (2013) -
Reproductive outcomes of female patients with congenital adrenal hyperplasia due to 21-hydroxylase defi ciency
por: Mnif, Mouna Feki, et al.
Publicado: (2013) -
Leydig Cell Tumor Associated with Testicular Adrenal Rest Tumors in a Patient with Congenital Adrenal Hyperplasia due to 11β-Hydroxylase Deficiency
por: Charfi, Nadia, et al.
Publicado: (2012) -
Congenital adrenal hyperplasia: Treatment and outcomes
por: Kamoun, Mahdi, et al.
Publicado: (2013) -
Height outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Evidence from recent data
por: Kamoun, Mahdi, et al.
Publicado: (2013)